# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2101-2110 of 2220 results.
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers
Status: Completed
Last Changed: Jul 14, 2020
First Received: May 05, 2010
Disease(s): Lymphoma, Mantle-cell, CLL (Chronic Lymphocytic Leukemia), Monoclonal B-Cell Lymphocytosis, Healthy Volunteers, Small Lymphocytic Lymphoma
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
Status: Terminated
Last Changed: Jul 16, 2012
First Received: Jan 27, 2003
Disease(s): Lymphoma
Intervention(s): radiation therapy
Locations: U.Z. Gasthuisberg, Leuven, Belgium
Universitair Medisch Centrum St. Radboud - Nijmegen, Leuven, Belgium
University Hospital Rebro, Zagreb, Croatia
Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
National Cancer Institute of Egypt, Cairo, Egypt
... and 11 other locations.
AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma
Status: Completed
Last Changed: Apr 08, 2020
First Received: Oct 19, 2006
Disease(s): Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
Intervention(s): CDKI AT7519, laboratory biomarker analysis
Locations: Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada
Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma
Status: Completed
Last Changed: Apr 08, 2020
First Received: Mar 07, 2007
Disease(s): Non-Hodgkins Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
Intervention(s): Aurora kinase inhibitor AT9283
Locations: BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
Ottawa Health Research Institute - General Division, Ottawa, Ontario, Canada
Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)
Status: Active, not recruiting
Last Changed: Jul 29, 2019
First Received: Apr 09, 2013
Disease(s): Haematological Malignancies
Intervention(s): CD25/71 allodepleted donor T-cells
Locations: University College London Hospital, London, United Kingdom
Manchester Royal Infirmary, Manchester, United Kingdom
A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)
Status: Terminated
Last Changed: Aug 13, 2014
First Received: Nov 01, 2009
Disease(s): Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Intervention(s): Lenalidomide, Rituximab, and Cyclophosphamide
Locations: Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
Status: Terminated
Last Changed: Jun 14, 2017
First Received: Jul 22, 2008
Disease(s): Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
Intervention(s): anti-thymocyte globulin, cyclophosphamide, cyclosporine, fludarabine phosphate, mycophenolate mofetil, umbilical cord blood transplantation, total body irradiation
Locations: Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Status: Terminated
Last Changed: Jun 14, 2019
First Received: Apr 30, 2015
Disease(s): Solid Tumors and Hematologic Malignancy
Intervention(s): INCB054329 Monotherapy
Locations: Cedars-Sinai Medical Center, Los Angeles, California, United States
University of California, San Francisco, Medical Center at Mount Zion, San Francisco, California, United States
Sarah Cannon Research Institute Research Center, Denver, Colorado, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
The University of Chicago Medical Center, Chicago, Illinois, United States
... and 8 other locations.
A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma
Status: Recruiting
Last Changed: Jun 25, 2019
First Received: Jan 29, 2015
Disease(s): Leukemia, Lymphoma
Intervention(s): Chimeric Antigen Receptor Modified T cells Targeting CD19
Locations: Southwest Hospital of Third Millitary Medical University, Chongqing, Chongqing, China
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies
Status: Recruiting
Last Changed: Apr 22, 2020
First Received: Mar 17, 2017
Disease(s): Advanced Solid Tumors, Cancer, Hematologic Malignancies
Intervention(s): ABBV-621, Venetoclax, Bevacizumab, FOLFIRI
Locations: Yale University /ID# 158029, New Haven, Connecticut, United States
University of Chicago /ID# 158030, Chicago, Illinois, United States
Ingalls Memorial Hosp /ID# 171221, Harvey, Illinois, United States
Illinois Cancer Care, PC /ID# 214998, Peoria, Illinois, United States
Univ Michigan Med Ctr /ID# 207134, Ann Arbor, Michigan, United States
... and 16 other locations.